Shionogi Enters Growing Pool Of Japanese Firms Developing Hay Fever Therapies
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Shionogi has signed an exclusive partnership with French firm Stallergenes for two sublingual allergy products, joining the ranks of Japanese biotech firms hoping to tap into Japan's hay fever market